(Q44103318)

29 November 2017

title

Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma (English)

1 reference

29 November 2017

main subject

multiple drug resistance

1 reference

Heidi Schwarzenbach

1

1 reference

29 November 2017

publication date

1 January 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

19

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

87-104

1 reference

Phenotypic difference of normal plasma cells from mature myeloma cells

29 November 2017

cites work

1 reference

12 December 2020

Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.

1 reference

12 December 2020

Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.

1 reference

12 December 2020

Chemotherapy resistance in acute myeloid leukaemia

1 reference

12 December 2020

Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cells

1 reference

12 December 2020

In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain

1 reference

12 December 2020

Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells.

1 reference

12 December 2020

Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens

1 reference

12 December 2020

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

1 reference

12 December 2020

Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity.

1 reference

12 December 2020

VAD-Cyclosporine Therapy for VAD-Resistant Multiple Myeloma

1 reference

12 December 2020

Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction

1 reference

12 December 2020

Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer

1 reference

12 December 2020

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma

1 reference

12 December 2020

P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.

1 reference

12 December 2020

Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns

1 reference

12 December 2020

Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer

1 reference

12 December 2020

Glutathione-dependent binding of a photoaffinity analog of agosterol A to the C-terminal half of human multidrug resistance protein

1 reference

12 December 2020

Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme

1 reference

12 December 2020

Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay

1 reference

12 December 2020

MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents.

1 reference

12 December 2020

Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma

1 reference

12 December 2020

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

1 reference

12 December 2020

A new structural model for P-glycoprotein

1 reference

12 December 2020

Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia

1 reference

12 December 2020

Multidrug resistance-associated protein (MRP) in haematological malignancies

1 reference

12 December 2020

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining

1 reference

12 December 2020

Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation

1 reference

12 December 2020

Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with Neuroblastoma

1 reference

12 December 2020

Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein

1 reference

12 December 2020

Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.

1 reference

12 December 2020

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

1 reference

12 December 2020

Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia

1 reference

12 December 2020

Identification of immature and mature myeloma cells in the bone marrow of human myelomas

1 reference

12 December 2020

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

1 reference

12 December 2020

Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.

1 reference

12 December 2020

Up-regulation of transporters of the MRP family by drugs and toxins

1 reference

12 December 2020

Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma

1 reference

12 December 2020

Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype

1 reference

12 December 2020

Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance

1 reference

12 December 2020

Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies

1 reference

12 December 2020

Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells

1 reference

12 December 2020

Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.

1 reference

12 December 2020

Proposed guidelines for protocol studies. II. Plasma cell myeloma. Prepared by a Committee of the Chronic Leukemia--Myeloma Task Force, National Cancer Institute

1 reference

12 December 2020

Analysis of multidrug‐resistance (MDR‐1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma

1 reference

12 December 2020

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations

1 reference

12 December 2020

Prognostic factors in multiple myeloma: selection using Cox's proportional hazard model

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:19:2:87

1 reference

Dimensions Publication ID

29 November 2017

1010100940

0 references

1 reference